ENTA Price / Book | ENANTA PHARMACEUTICALS, INC

ENANTA PHARMACEUTICALS, INC (ENTA) Price / Book

2026-09-03: Price/Book Ratio 4.04.
2026-06-30: Price/Book Ratio 4.2.
2026-03-31: Price/Book Ratio 3.15.
2025-12-31: Price/Book Ratio 3.62.

Historical market capitalization divided by filed shareholder equity.

Available history: 2013-03-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	4.04
2026-06-30	4.2
2026-03-31	3.15
2025-12-31	3.62
2025-09-30	3.96
2025-06-30	2.04
2025-03-31	1.26
2024-12-31	1.1
2024-09-30	1.72
2024-06-30	1.84
2024-03-31	2.23
2023-12-31	1.04
2023-09-30	1.09
2023-06-30	1.89
2023-03-31	3.16
2022-12-31	3.23
2022-09-30	3.36
2022-06-30	2.9
2022-03-31	4.09
2021-12-31	3.99
2021-09-30	2.88
2021-06-30	2.13
2021-03-31	2.28
2020-12-31	1.88
2020-09-30	2.02
2020-06-30	2.1
2020-03-31	2.12
2019-12-31	2.54
2019-09-30	2.56
2019-06-30	3.71
2019-03-31	4.31
2018-12-31	3.23
2018-09-30	4.21
2018-06-30	6.22
2018-03-31	4.67
2017-12-31	3.54
2017-09-30	2.97
2017-06-30	2.63
2017-03-31	2.21
2016-12-31	2.38
2016-09-30	1.88
2016-06-30	1.56
2016-03-31	2.09
2015-12-31	2.35
2015-09-30	2.86
2015-06-30	3.69
2015-03-31	2.55
2014-12-31	4.89
2014-09-30	4.95
2014-06-30	5.23
2014-03-31	7.26
2013-12-31	4.64
2013-09-30	3.72
2013-06-30	2.76
2013-03-31	2.74

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Emergent BioSolutions Inc. (EBS)	United States	$0.347B	-2.43
Larimar Therapeutics, Inc. (LRMR)	United States	$0.344B	-1.83
Vogenx, Inc. (VOGX)	United States	$0.355B
Benitec Biopharma Inc. (BNTC)	United States	$0.337B	-10.08
BioAge Labs, Inc. (BIOA)	United States	$0.333B	-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)	United States	$0.320B	-3.35
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63